in vitro studies confirm that the combination of a beta-lactamase inhibitor and a beta-lactam can increase the activity of the beta-lactam to such important pathogens as s aureus , klebsiella , h influenzae , bacteroides spp and other bacteria which produce plasmid-mediated beta-lactamase .
C0004611
bacteria
C0597979
beta-lactamase